EU reviewing cases of rare body inflammation after COVID-19 shots

The European Medicines Agency's safety committee is also looking into cases of blood clots in the vein with Johnson & Johnson's COVID-19 vaccine, the regulator said, adding that the issue was distinct from a rare side-effect identified earlier.

Reuters
European Medicines Agency's safety committee is also looking into cases of blood clots in the vein with Johnson & Johnson's COVID-19 vaccine
Europe's medicines regulator said on Friday it was reviewing cases of multisystem inflammatory syndrome after inoculation with COVID-19 vaccines, following a report of a similar case with Pfizer/BioNTech's shot.

The European Medicines Agency's safety committee is also looking into cases of blood clots in the vein with Johnson & Johnson's COVID-19 vaccine, the regulator said, adding that the issue was distinct from a rare side-effect identified earlier.
Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › News › International › World News › EU reviewing cases of rare body inflammation after COVID-19 shots
Text Size:AAA
Success
This article has been saved

*

+